Nanjing BioPoint Shoots For 2018 Double POC Launch; Seeks $10m
Executive Summary
A China-based IVD company, spun out of an Australian medical research institute, is seeking investors to support its plans for the 2018 launch its first two point-of-care tests for patients with infectious diseases including HIV and viral hepatitis.